We report on the molecular characterization of two acute myeloid leukemias (AML), one AML-M1 (patient 1) and one AML-M2 (patient 2) with t(8;21)(p21;q22) and t(8;20)(q22;p13), respectively, at diagnosis. The locations of the breakpoints, 21q22 in patient 1 and 8q22 in patient 2, prompted us to searc
β¦ LIBER β¦
Molecular pathogenesis of AML (mouse models of acute myeloid leukemia with AML1-ETO fusion proteins)
β Scribed by Dong-Er Zhang
- Book ID
- 105720633
- Publisher
- Carden Jennings Publishing
- Year
- 2002
- Tongue
- English
- Weight
- 207 KB
- Volume
- 76
- Category
- Article
- ISSN
- 0925-5710
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Simple variant t(8;21) acute myeloid leu
β
Sylvie Taviaux; VΓ©ronique Brunel; Madeleine Dupont; Francisca Fernandez; Concepc
π
Article
π
1999
π
John Wiley and Sons
π
English
β 576 KB
Expression of MAC-1 (CD11b) in acute mye
β
Michaela Graf; Susanne Reif; Tanja KrΓΆll; Karin Hecht; Volkmar Nuessler; Helga S
π
Article
π
2006
π
John Wiley and Sons
π
English
β 367 KB
π 2 views
Fluorescence In Situ Hybridization Detec
β
Kosuke Obama; Mitsutoshi Tara; Kiyoshige Niina
π
Article
π
2003
π
Carden Jennings Publishing
π
English
β 335 KB
CD34-related coexpression ofMDR1 and BCR
β
Marry M. van den Heuvel-Eibrink; Bronno van der Holt; Alan K. Burnett; Wolfgang
π
Article
π
2007
π
Springer
π
English
β 207 KB
PRDX4, a member of the peroxiredoxin fam
β
Yanming Zhang; Neelmini Emmanuel; Ginny Kamboj; Jianjun Chen; Muhammad Shurafa;
π
Article
π
2004
π
John Wiley and Sons
π
English
β 210 KB
π 1 views
## Abstract The __AML1__ gene (also known as __RUNX1__) at 21q22 codes for core binding factor (CBF) Ξ±, which forms a heterodimer with CBF Ξ² that acts as a transcriptional activating factor. CBF is a critical regulator in the generation and differentiation of definitive hematopoietic stem cells and